Phio Pharmaceuticals Corporation (PHIO)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -2.73M | -3.6M | -2.55M | -2.78M | -1.9M | -2.21M | -1.91M | -1.59M |
税引前収入 | -2.73M | -3.6M | -2.55M | -2.77M | -1.9M | -2.15M | -1.85M | -1.52M |
純利益 | -2.73M | -3.6M | -2.55M | -2.78M | -1.9M | -2.15M | -1.85M | -1.52M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -2.73M | -3.6M | -2.55M | -2.78M | -1.9M | -2.15M | -1.85M | -1.52M |
EBITDA | -2.72M | -3.59M | -2.53M | -2.76M | -1.76M | -2.21M | -1.91M | -1.59M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 19k | 15k | 138k | 21k | 0 | 0 | 0 | 0 |
営業利益 | -9.02M | -14.06M | -7.36M | -8.99M | -8.79M | -13.51M | -11.46M | -10.82M |
税引前収入 | -8.99M | -14.07M | -7.36M | -8.91M | -8.79M | -13.29M | -11.48M | -10.83M |
純利益 | -11.07M | -12.45M | -7.36M | -8.91M | -8.79M | -13.29M | -11.48M | -10.83M |
優先配当 | -2.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.851 | -5.124 | -0.391 | -13.315 | -1.521 | -0.982 | -10.079 | -4.431 |
EBIT | -9.01M | -14.07M | -7.36M | -8.91M | -8.79M | -13.28M | -11.48M | -10.83M |
EBITDA | -8.96M | -13.99M | -7.28M | -8.92M | -8.72M | -13.44M | -11.39M | -10.64M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約